chinese-drugstore-climbs-on-us-debut

Chinese drugstore climbs on US debut

China Nepstar raises $334.1 million after pricing its IPO 20% above the range - the maximum allowed on a US offering.
China Nepstar Chain Drugstore had a solid debut on the New York Stock Exchange on Friday after pricing its initial public offering 20% above the original price range, suggesting that the demand for Chinese growth stocks continues. The final price allowed it to raise $334.1 million, making it the third largest US IPO by a private-sector Chinese company this year.

The debut was keenly watched after Chinese upstream agricultural solutions company Agria Corp tumbled 26.9% on its first day of trading on Wednesday. The market as a whole is also starting to look a bit shakier with NepstarÆs first day of trading coinciding with a third straight day of losses for the Dow Jones index....
¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222